Found: 13
Select item for more details and to access through your institution.
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 1, doi. 10.1159/000524556
- Publication type:
- Article
APPLE News.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 184, doi. 10.1159/000524373
- Publication type:
- Article
Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 87, doi. 10.1159/000523702
- By:
- Publication type:
- Article
Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar Cholangiocarcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 162, doi. 10.1159/000521613
- By:
- Publication type:
- Article
LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 126, doi. 10.1159/000521595
- By:
- Publication type:
- Article
The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 113, doi. 10.1159/000521358
- By:
- Publication type:
- Article
Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 152, doi. 10.1159/000521227
- By:
- Publication type:
- Article
Treatments for the Early-Stage Hepatocellular Carcinoma: Laparoscopic Liver Resection or Percutaneous Radiofrequency: How to Make a Decision?
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 178, doi. 10.1159/000521136
- By:
- Publication type:
- Article
Reply to Rizzo et al.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 182, doi. 10.1159/000521101
- By:
- Publication type:
- Article
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 94, doi. 10.1159/000520501
- By:
- Publication type:
- Article
Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 180, doi. 10.1159/000520481
- By:
- Publication type:
- Article
Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 141, doi. 10.1159/000518837
- By:
- Publication type:
- Article